Ambulatory Surgery Center Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Market Trends and Insights

Expansion of CMS-Approved ASC Procedure List Accelerating High-Acuity Shift

The CY 2025 Hospital Outpatient Prospective Payment System final rule added 20 complex interventions, including select percutaneous coronary procedures, to the ambulatory list.^{[1]Centers for Medicare & Medicaid Services, “CY 2025 Hospital Outpatient Prospective Payment System Final Rule,” cms.gov}Centers that upgrade imaging suites and credential multidisciplinary teams are already capturing new referral streams and securing premium commercial contracts. Cardiovascular throughput is expected to sustain a 9.65% CAGR to 2030, giving early movers a defensible payor-mix advantage. Larger health systems are converting underutilised hospital outpatient departments into dedicated hybrid ASCs to comply with the 24-hour discharge rule while tapping higher case volumes.

Certificate-of-Need Deregulation Enabling Rapid Build-Outs

Legislative rollbacks in Georgia, Florida, and West Virginia are lowering barriers to entry for greenfield developments. Georgia’s HB 1339, in force since July 2024, exempts many new centers from the previous CON process, prompting a pipeline of more than 30 filings in metro Atlanta alone. Operators with sophisticated site-selection analytics are locking in leases near population growth corridors ahead of rivals and leveraging local physician partnerships to accelerate payer credentialing. The pace of filings indicates a likely supply surge that could compress occupancy in the medium term yet should widen patient access in historically underserved suburbs.

High-Deductible Health Plans & Price Transparency Steering Patients Toward Low-Cost ASCs

Across the United States, average ASC commercial pricing sits at 162% of Medicare versus 234% for hospital outpatient departments, yielding material savings for cost-sensitive patients.^{[2]RAND Corporation, “Nationwide Commercial Price Transparency Study,” rand.org} Mandated hospital price-posting and employer-sponsored transparency tools are making relative price differentials visible at the consumer level. Centers that package procedures into all-inclusive bundles and market predictable invoices are winning direct-to-employer contracts, siphoning elective volumes out of traditional hospital channels.

AI-Driven Workflow Solutions Raising Throughput in Ophthalmology & Orthopedics

AI-powered scheduling reduced case cancellations by 27% and improved on-time starts by 34% in a 2024 multi-state network study.^{[3]Agency for Healthcare Research and Quality, “Artificial Intelligence in Ambulatory Surgery Centers,” ahrq.gov} In ophthalmology suites, computer-assisted diagnostic scoring cuts pre-operative assessment times by 41%, allowing cataract centers to add two to three additional cases per room each day. Higher throughput not only boosts margins but also raises surgeon satisfaction, which in turn drives physician referral loyalty.

Peri-operative Nurse & Anesthetist Shortages Limiting OR Utilisation Rates

The supply of certified registered nurse anesthetists remains below demand, especially in rural markets where they are often the sole anaesthesia providers. Rising wage inflation and burnout have compounded recruitment challenges, forcing some centers to cap block times even when demand exists. Operators are responding with accelerated residency pipelines and tuition assistance agreements tied to multi-year employment contracts. Centers that offer flexible scheduling and clinical ladders are holding turnover to the low single digits, sustaining utilisation levels.

Reimbursement Gaps vs HOPD Eroding Margins in Cardiac & Spine Cases

Although CMS granted ASCs a 2.9% payment increase for 2025, the site-of-service differential on high-acuity codes persists. Capital-intensive cardiac and spine procedures can still carry thinner margins at ASCs than in hospital outpatient departments, pressuring independent centers to reassess case mixes. Many are entering joint ventures with health systems that contribute equipment capital and extend higher commercial rates, helping sustain financial viability without sacrificing operational agility.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Ambulatory Surgery Center Market Segment Analysis

Single-specialty centers generated 61.78% of 2025 revenue, underpinned by clinically efficient musculoskeletal, ophthalmic, and pain-management service lines. The operators of single-specialty sites reported average same-room turnover times under 14 minutes, a key factor in physician loyalty. Focused staffing models, equipment reuse, and aligned implant formularies have historically driven EBITDA margins into the mid-30% range.

Multi-specialty centers, while smaller today, are forecast to outgrow single-discipline peers at 8.09% annually through 2031. Diversified case mixes cushion reimbursement volatility and boost scheduling density across the week. Larger systems are layering endoscopy, ENT, and women’s health into existing orthopedic hubs, raising yield on fixed costs. This pivot is expected to push the multi-specialty slice of the ambulatory surgical centers market share several points higher over the next five years.

Freestanding facilities held 66.10% of 2025 revenue. Their independence from hospital campuses allows flexible site selection near high-income suburbs and employer clusters, a distinct access advantage. Many also operate extended hours, capturing after-work cases that hospitals struggle to schedule.

Hospital-based ASCs represented 33.90% of revenue but are set to grow at a 8.76% CAGR. Health systems are converting underused procedural suites into compliant ambulatory sites to defend referral bases and secure downstream imaging and inpatient volumes. Early evidence suggests that alignment with hospital electronic health records shortens referral cycles, driving incremental growth. This shift should steadily lift the hospital-affiliated slice of the ambulatory surgical centers market size, especially for spine and structural heart programs that demand costly imaging infrastructure.

Physician owners commanded 59.35% of revenue in 2025, a testament to surgeon preference for clinical autonomy. Average distributions per partner remained attractive even after the 2.9% Medicare rate adjustment, keeping many single-site ventures independent. Yet corporate and private-equity platforms, benefiting from 7× EBITDA buyout leverage, are expanding at a 9.74% CAGR. Scale unlocks payer-contract clout, supply-chain rebates, and shared revenue-cycle services. Consequently, the corporate slice of the ambulatory surgical centers market share is likely to climb despite entrenched physician ownership.

Joint-venture structures offer a middle path, mixing surgeon governance with hospital capital. Tenet Healthcare’s USPI portfolio grew to 438 centers by 2021 and targets 575-600 by 2025, with management projecting ASC contributions to about half of adjusted EBITDA. Similar deals are rising in cardiovascular and gastroenterology niches where device costs are high.

Surgical procedures produced 76.65% of 2025 revenue, reflecting that orthopedic joint replacement, cataract extraction, and pain injections remain top volume drivers. The ambulatory surgical centers market size for surgery is forecast to rise steadily, buoyed by expanding CPT approvals.

Diagnostic imaging and ancillary testing, comprising 23.35% of revenue, are poised for 9.18% annual growth. Centers adding on-site MRI or CT gain scheduling control and retain downstream income. CMS telehealth parity and caregiver-training codes, effective 2025, further support non-procedural revenue streams, strengthening diversification strategies.

Orthopedics accounted for 29.78% of 2025 revenue and remains the anchor specialty. Predictable implant pricing, bundled payment familiarity, and robotic-assisted knee technology keep volumes high. The ambulatory surgical centers market maintains orthopedics as its most enormous pillar even as musculoskeletal reimbursement tightens.

Cardiovascular procedures, newly liberated by CMS site-of-service updates, will scale at a 9.18% CAGR. Early adopters are investing in hybrid cath labs and ICP-qualified nursing skill sets. Higher case complexity raises average revenue per procedure, positioning cardiology as a key earnings accelerator through 2031.

Geography Analysis

North America Ambulatory Surgery Center Market

North America captured 36.10% of 2025 revenue, cementing its leadership position. Continued Certificate-of-Need rollbacks and consistent CMS payment updates encourage regional expansion. Robotic-enabled spine programs, underpinned by a USD 1 million donation to Halifax’s QEII Health Sciences Centre in January 2024, showcase the region’s tilt toward technology-rich high-acuity cases. These investments should lift regional case acuity and support modest pricing power despite payer scrutiny.

Europe Ambulatory Surgery Center Market

Europe presents a more heterogeneous adoption pattern. The United Kingdom, Germany, and France lead development, each leveraging public-private partnership frameworks that balance access mandates with private-sector efficiency. Stringent postoperative quality metrics and integrated care pathways support steady conversion of day-case potential into ambulatory volumes.

APAC Ambulatory Surgery Center Market

Asia delivers the fastest expansion, logging a projected 9.95% CAGR through 2031. Rising middle-class demand, private health-insurance growth, and public incentives for infrastructure build-outs spur construction across China and India. Multinational operators are trial-launching joint-venture ASCs within tertiary hospitals to mitigate regulatory risk while capturing self-pay demand. As procedure migration takes hold, the Asian contribution to global ambulatory surgical centers market share is set to rise materially.

Market Opportunities and Future Outlook

White-space is forming where payer and regulator actions broaden the outpatient site-of-service envelope, especially for higher-acuity cardiovascular and spine pathways that depend on imaging, anesthesia depth, and stricter discharge readiness. The CY 2025 Hospital Outpatient Prospective Payment System final rule added 20 complex interventions, including select percutaneous coronary procedures, to the ambulatory list. CMS also refined its nomination process for adding new procedures to the ASC list in December 2024, which improves the pathway for stakeholders to pursue additional codes into ASC reimbursement.

Alongside this, state-level Certificate-of-Need rollbacks, including Georgia HB 1339 effective July 1, 2024, have accelerated greenfield filings and intensified site selection around growing suburbs and secondary cities. Operator strategies are creating investable opportunities in multi-specialty conversion, revenue-cycle automation, and employer-led contracting, supported by reported price differentials (162% of Medicare for ASCs versus 234% for hospital outpatient departments) and an increased focus on total-cost-of-care. In parallel, consolidation is reshaping where competition concentrates: corporate-backed sites are the fastest-growing ownership segment in the report context, and large system-platform activity (for example, Ascension completing its acquisition of AMSURG in June 2026) points to continued integration of physician-aligned outpatient assets alongside joint ventures that bring hospital capital to high-acuity service lines.